Camp4 Therapeutics Corporation
CAMP
$2.13
-$0.01-0.47%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -51.79M | -51.50M | -49.71M | -49.50M | -49.29M |
| Total Depreciation and Amortization | 1.70M | 1.71M | 1.73M | 1.70M | 1.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.86M | 5.67M | 4.74M | 4.73M | 4.73M |
| Change in Net Operating Assets | -1.33M | -1.94M | 334.00K | -467.50K | -1.27M |
| Cash from Operations | -45.56M | -46.06M | -42.92M | -43.54M | -44.16M |
| Capital Expenditure | -441.00K | -421.00K | -628.00K | -653.00K | -678.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -441.00K | -421.00K | -628.00K | -653.00K | -678.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 353.00K | 706.00K |
| Total Debt Repaid | -824.00K | -849.00K | -848.00K | -719.00K | -590.00K |
| Issuance of Common Stock | 76.47M | 206.00K | 176.00K | 180.50K | 185.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.98M | -820.00K | -608.00K | -304.00K | -- |
| Cash from Financing | 71.66M | -1.46M | -1.28M | -489.50K | 301.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.66M | -47.94M | -44.83M | -44.68M | -44.53M |